The psychedelic-themed event will be hosted by Proactive’s Christine Corrado and kicks off on Tuesday at 1 PM ET.
Lobe Sciences is mastering the development of transformational medicines and devices as it builds a growing portfolio of intellectual property to support wellness and improve mental health.
The Vancouver-based company is currently advancing unique medicines and devices to treat mild traumatic brain injury and post-traumatic stress disorder, as well as other indications. With five provisional patents, a pre-clinical study underway and a drug delivery device in engineering development, Lobe is quickly making a name for itself in the world of psychedelics.
In December, Lobe sold its cannabis asset Cowlitz County Cannabis Cultivation to Ionic Brands, netting $23 million and a stake in the latter company to keep a foothold in the red-hot US cannabis space.
CEO Phil Young will share the company’s plans for the proceeds and other strategic initiatives on its plate for 2021 with participants on Tuesday.